AR020158A1 - Mejorador del factor de induccion para la diferenciacion celular - Google Patents

Mejorador del factor de induccion para la diferenciacion celular

Info

Publication number
AR020158A1
AR020158A1 ARP990104011A ARP990104011A AR020158A1 AR 020158 A1 AR020158 A1 AR 020158A1 AR P990104011 A ARP990104011 A AR P990104011A AR P990104011 A ARP990104011 A AR P990104011A AR 020158 A1 AR020158 A1 AR 020158A1
Authority
AR
Argentina
Prior art keywords
cell differentiation
induction factor
factor improver
improver
optionally substituted
Prior art date
Application number
ARP990104011A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AR020158A1 publication Critical patent/AR020158A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invencion provee un mejorador de factor de induccion de diferenciacion celular que comprende un compuesto de formula (1), en donde el anillo A es unanillo de benceno opcionalmente sustituido; R es un átomo de hidrogeno o un grupo hidrocarburo opcionalmente sustituido; B es un grupo carboxiloopcionalmente esterificado o amidado; X es -CH(OH)- o -CO-; k es 0 o 1; y k es 0, 1 o 2; o su sal, que puede ser ventajosamente usado comoun mejorador de factor de induccion de diferenciacion celular.
ARP990104011A 1998-08-12 1999-08-11 Mejorador del factor de induccion para la diferenciacion celular AR020158A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22830098 1998-08-12

Publications (1)

Publication Number Publication Date
AR020158A1 true AR020158A1 (es) 2002-04-10

Family

ID=16874304

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104011A AR020158A1 (es) 1998-08-12 1999-08-11 Mejorador del factor de induccion para la diferenciacion celular

Country Status (5)

Country Link
EP (1) EP1105140A2 (es)
AR (1) AR020158A1 (es)
AU (1) AU5196099A (es)
CA (1) CA2340165A1 (es)
WO (1) WO2000009100A2 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE203020T1 (de) * 1990-05-30 2001-07-15 Takeda Chemical Industries Ltd Schwefel enthaltende heterocyclische verbindungen
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
AU4677496A (en) * 1995-02-21 1996-09-11 Takeda Chemical Industries Ltd. Use of helioxanthin as an enhancer of cell differentiation inducing factors
RU2188011C2 (ru) * 1995-06-05 2002-08-27 Такеда Кемикал Индастриз, Лтд. Активирующая остеогенез фармацевтическая композиция
CA2264131A1 (en) * 1996-08-26 1998-03-05 Takeda Chemical Industries, Ltd. Pharmaceutical composition containing osteogenesis-promoting substance
EP0931074B1 (en) * 1996-09-06 2003-05-07 Takeda Chemical Industries, Ltd. Condensed 4,5,6,7-tetrahydrobenzo c]thiophenes as enhancer for cell differentiation induction factor action

Also Published As

Publication number Publication date
WO2000009100A2 (en) 2000-02-24
CA2340165A1 (en) 2000-02-24
WO2000009100A3 (en) 2000-08-24
EP1105140A2 (en) 2001-06-13
AU5196099A (en) 2000-03-06

Similar Documents

Publication Publication Date Title
NO992375D0 (no) FremgangsmÕte for fremstilling av benzylethere
CO4780028A1 (es) Procedimiento para la preparacion de sildenafil
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
ES2142123T3 (es) Derivados de organosiloxanilo de alcanodiol-monovinil-eteres, proceso para su preparacion, su modificacion y su empleo como aditivos para barnices.
ATE248146T1 (de) Arylalkylpiperazin-verbindungen als antioxidantien
ES2060578T3 (es) Sintesis de compuestos tipo podofilotoxina.
DK0460488T3 (da) Svovlholdige heterocykliske forbindelser
ES2155991T3 (es) Nuevos compuestos de terfenilo y medicamentos que contienen estos compuestos.
ES2017596T3 (es) Un nuevo proceso para intermediarios de carbapen.
BR9509741A (pt) Composto e uso de composto
AR020158A1 (es) Mejorador del factor de induccion para la diferenciacion celular
NO953420L (no) Oksa- eller tiaalifatiske broinneholdende chinoksalin-2-dioner
KR860001108A (ko) 페닐-나프티리딘의 제조방법
ATE209205T1 (de) Indan-2-mercaptoacetylamid disulfidderivate als enkephalinase inhibitoren
EA200001036A1 (ru) Способы ингибирования mrp1
AR019664A1 (es) Composicion para el tratamiento de enfermedades del cartilago
BR0007897A (pt) Uso de derivados anticonvulsivantes para otratamento de bulimia nervosa
DE60010276T2 (de) Neuartige vitamin-d analoge
ES8801670A1 (es) Un procedimiento para preparar nuevos compuestos de 2-oxa pregnano.
FI820240L (fi) Nytt framstaellningsfoerfarande foer 17alfa-hydroxi-17beta-hydroxiacetylsteroider och pao motsvarande saett erhaollna mellanprodukter
ES2077321T3 (es) Procedimiento para la obtencion de 2,2-bis-hidroximetil-butanodiol-(1,4).
ES2090777T3 (es) Procedimiento para el curtido de cuero y pieles.
ES2062184T3 (es) Procedimiento para la fabricacion de 4-amino-1,2,4-triazol-5-onas.
DE59002172D1 (de) Neue 1,3-oxazine.
BR9714825A (pt) Composição fluoroquìmica para o tratamento de couro, processo de tratamento de couro, uso de uma composição fluoroquìmica, produto de reação de um polidieno enxertado, e, sal do produto de reação